background
previou
studi
support
strong
associ
viral
respiratori
tract
infect
asthma
exacerb
effect
newli
discov
virus
asthma
control
less
well
defin
object
sought
determin
contribut
respiratori
virus
asthma
exacerb
children
panel
pcr
assay
common
newli
discov
respiratori
virus
method
respiratori
specimen
children
age
year
asthma
exacerb
case
patient
n
wellcontrol
asthma
control
subject
n
frequenc
match
age
season
enrol
test
rhinovirus
enterovirus
respiratori
syncyti
viru
human
metapneumoviru
coronavirus
parainfluenza
virus
influenza
virus
adenovirus
human
bocaviru
result
infect
respiratori
virus
associ
asthma
exacerb
case
patient
vs
control
subject
odd
ratio
ci
rhinoviru
far
preval
viru
among
case
patient
vs
among
control
subject
viru
significantli
associ
exacerb
odd
ratio
ci
howev
children
without
clinic
manifest
viral
respiratori
tract
ill
preval
rhinoviru
infect
similar
case
patient
versu
control
subject
p
virus
detect
includ
human
metapneumoviru
patient
acut
asthma
vs
control
subject
enterovirus
vs
coronaviru
vs
respiratori
syncyti
viru
vs
conclus
symptomat
rhinoviru
infect
import
contributor
asthma
exacerb
children
clinic
implic
result
support
need
therapi
effect
rhinoviru
mean
decreas
asthma
exacerb
j
allergi
clin
immunol
decad
viral
respiratori
tract
infect
report
import
trigger
exacerb
asthma
adult
children
earli
studi
base
nonmolecular
mean
detect
viral
infect
identifi
fewer
acut
asthma
episod
result
recent
studi
base
pcr
assay
support
much
greater
role
viral
respiratori
tract
infect
acut
asthma
wide
rang
respiratori
virus
includ
rhinovirus
respiratori
syncyti
viru
rsv
influenza
virus
coronavirus
human
parainfluenza
virus
enterovirus
human
metapneumoviru
hmpv
recent
discov
human
bocaviru
detect
patient
asthma
exacerb
rhinovirus
current
recogn
common
respiratori
viru
associ
acut
asthma
schoolag
children
wherea
rsv
appear
common
respiratori
viru
associ
wheez
episod
asthma
young
children
consid
discoveri
new
virus
recent
progress
develop
drug
effect
respiratori
virus
determin
spectrum
virus
associ
asthma
exacerb
contribut
potenti
treatabl
agent
import
evalu
intervent
strategi
aim
decreas
asthma
morbid
thu
addit
epidemiolog
studi
necessari
better
understand
relationship
respiratori
virus
asthma
exacerb
conduct
casecontrol
studi
evalu
extent
associ
differ
respiratori
virus
asthma
exacerb
children
use
full
panel
pcr
assay
respiratori
virus
includ
newli
discov
bocaviru
pediatr
patient
asthma
sought
treatment
urban
children
medic
center
invit
particip
abbrevi
use
hmpv
human
metapneumoviru
odd
ratio
rsv
respiratori
syncyti
viru
observ
casecontrol
studi
studi
protocol
recruit
advertis
consent
form
approv
institut
review
board
emori
univers
school
medicin
children
healthcar
atlanta
egleston
hospit
center
diseas
control
prevent
legal
author
repres
children
provid
inform
consent
children
appropri
provid
assent
studi
coordin
collect
clinic
inform
biolog
specimen
particip
fulfil
studi
criteria
current
persist
asthma
tabl
particip
classifi
case
patient
control
subject
physician
investig
time
enrol
difficulti
differenti
asthma
wheez
episod
origin
young
children
lower
age
limit
studi
group
year
criteria
case
patient
control
subject
well
clinic
manifest
respiratori
tract
viral
ill
defin
symptom
list
tabl
capac
detect
viral
respiratori
infect
time
sensit
rel
onset
symptom
particip
acut
exacerb
asthma
enrol
within
hour
admiss
hospit
account
known
agerel
season
variat
occurr
viral
infect
frequenc
match
case
patient
control
subject
age
season
enrol
obtain
respiratori
secret
particip
use
nasopharyng
throat
swab
respiratori
specimen
held
transport
ice
pack
virolog
laboratori
center
diseas
control
prevent
pulmonari
function
measur
calibr
spiromet
koko
pd
ferrari
louisvil
colo
best
forc
vital
capac
maneuv
result
fulfil
american
thorac
societi
criteria
reproduc
express
accord
refer
standard
hankinson
et
al
respiratori
swab
specimen
place
ml
rna
storag
solut
ambion
austin
tex
aliquot
fluid
ad
nuclisen
lysi
buffer
autom
nucleic
acid
extract
durham
nc
total
nucleic
acid
extract
approxim
ml
supplement
volum
rna
storag
solut
test
immedi
use
pcr
store
nucleic
acid
extract
test
picornavirus
use
primer
detect
rhinovirus
enterovirus
rsv
hmpv
human
parainfluenza
virus
influenza
virus
b
adenovirus
previous
describ
pcr
assay
panel
addit
specimen
test
human
coronavirus
human
bocaviru
use
realtim
pcr
assay
distinguish
rhinovirus
enterovirus
amplicon
picornaviru
pcrposit
sampl
sequenc
sequenc
compar
publish
sequenc
nation
institut
health
genet
sequenc
databas
genbank
nucleic
acid
extract
also
test
dehydrogenas
housekeep
gene
evalu
integr
nucleic
acid
extract
detect
pcr
inhibitor
assay
use
studi
detect
less
viral
target
rna
transcript
copi
rhinoviru
serotyp
perform
bivari
analys
use
x
fisher
exact
test
compar
preval
respiratori
virus
variabl
current
persist
asthma
children
age
follow
physician
diagnosi
asthma
previou
episod
cough
wheez
andor
respiratori
distress
current
treatment
asthma
medic
parent
sibl
current
past
diagnosi
asthma
allergi
andor
current
previou
evid
atopi
defin
season
rhiniti
eczema
food
hypersensit
children
age
follow
physician
diagnosi
asthma
symptom
asthma
past
mo
current
treatment
asthma
medic
case
current
persist
asthma
hospit
admiss
clinic
visit
asthma
exacerb
follow
presenc
sign
symptom
airflow
obstruct
within
past
h
eg
cough
wheez
short
breath
chest
tight
increas
asthma
symptom
result
hospit
admiss
clinic
visit
repeat
use
shortact
bagonist
within
past
h
increas
dose
addit
new
asthma
control
therapi
within
past
week
current
persist
asthma
routin
clinic
visit
asthma
follow
system
steroid
therapi
past
wk
increas
dose
addit
new
control
medic
past
week
chang
frequenc
use
shortact
rescu
medic
past
week
increas
asthma
symptom
frequenc
past
week
symptomat
acut
respiratori
viral
ill
follow
fever
stuffyrunni
nose
headach
muscl
ach
eye
red
pain
time
clinic
visit
hospit
admiss
studi
group
trend
proport
distribut
fev
viral
infect
asthma
exacerb
analyz
use
x
trend
test
test
statist
use
compar
mean
age
fev
express
percent
predict
asthma
exacerb
statu
p
valu
calcul
basi
test
use
multipl
logist
regress
analysi
model
log
odd
asthma
exacerb
associ
respiratori
tract
viral
infect
calcul
estim
odd
ratio
or
ci
logist
model
test
potenti
confound
eg
age
season
sex
effect
modifi
final
model
adjust
factor
eg
raceethn
collinear
confound
b
coeffici
associ
respiratori
tract
viral
infect
asthma
exacerb
addit
final
model
includ
frequencymatch
variabl
age
season
statist
procedur
perform
sa
version
softwar
sa
institut
inc
cari
nc
children
primari
diagnosi
asthma
treat
studi
hospit
treat
pulmonari
clinic
popul
elig
particip
studi
refus
enrol
common
reason
refus
anxieti
relat
nasal
swab
procedur
sixtyf
enrolle
acut
asthma
exacerb
wellcontrol
asthma
tabl
ii
particip
acut
asthma
enrol
hospit
refer
hospit
case
patient
enrol
pulmonari
clinic
nonhospit
case
patient
comparison
frequencymatch
case
patient
control
subject
show
mean
time
sinc
onset
asthma
differ
case
patient
control
subject
year
case
patient
significantli
like
control
subject
african
american
descent
visit
health
care
provid
acut
asthma
time
past
month
hospit
asthma
least
twice
past
month
ever
admit
intens
care
unit
asthma
symptom
respiratori
tract
viral
ill
enrol
tabl
ii
children
acut
exacerb
like
receiv
past
week
inhal
b
adrenerg
agonist
ipratropium
bromid
wherea
children
wellcontrol
asthma
like
treat
montelukast
group
differ
significantli
respect
treatment
inhal
corticosteroid
tabl
ii
none
children
receiv
antivir
agent
fortyseven
case
patient
treat
system
steroid
within
past
week
enrol
preval
selfreport
hay
fever
atopi
famili
histori
asthma
exposur
common
allergen
exposur
secondhand
smoke
differ
significantli
group
data
shown
case
patient
enrol
hospit
pulmonari
clinic
compar
demograph
featur
signific
differ
group
recent
use
medic
except
ipratropium
bromid
among
hospit
case
patient
vs
among
case
patient
treat
clinic
p
hospit
case
patient
significantli
like
hospit
admiss
past
month
vs
ci
signific
differ
proport
case
patient
health
care
provid
visit
acut
asthma
treatment
past
month
proport
case
patient
ever
admit
intens
care
unit
asthma
interv
onset
asthma
exacerb
hospit
clinic
visit
case
patient
fewer
day
patient
provid
inform
median
day
pcr
analysi
respiratori
specimen
posit
respiratori
virus
asthmat
patient
acut
exacerb
patient
control
asthma
p
x
test
tabl
iii
children
acut
asthma
exacerb
nearli
like
infect
respiratori
virus
children
control
asthma
ci
result
pcr
test
agent
present
tabl
iii
picornavirus
identifi
particip
instanc
picornavirusposit
specimen
confirm
posit
rhinovirus
far
common
respiratori
virus
detect
among
studi
particip
addit
rhinovirusposit
specimen
also
pcr
posit
enterovirusspecif
primer
indic
mix
infect
picornaviru
detect
mean
pcr
child
control
group
could
character
five
children
posit
hmpv
posit
rsv
posit
coronaviru
none
particip
posit
human
bocaviru
coronaviru
hpvi
influenza
virus
adenovirus
tabl
iii
four
children
coinfect
respiratori
viru
children
posit
rhinovirus
enterovirus
rsvposit
child
also
posit
hmpv
children
acut
asthma
posit
pcr
result
respiratori
virus
symptom
consist
acut
respiratori
tract
viral
infect
median
interv
onset
viral
symptom
specimen
collect
day
control
group
clinic
manifest
viral
ill
present
children
posit
result
respiratori
viru
presenc
symptom
viral
infect
taken
account
associ
asthma
exacerb
respiratori
virus
signific
children
symptom
acut
viral
ill
respiratori
tract
children
without
clinic
manifest
viral
infect
tabl
iii
associ
respiratori
tract
viral
infect
asthma
exacerb
remain
signific
control
raceethn
age
season
test
adjust
ci
case
patient
control
subject
preval
viral
infect
differ
significantli
among
children
age
fewer
year
versu
children
age
year
tabl
iv
assess
effect
asthma
sever
preval
viral
infect
analyz
proport
virusposit
children
use
avail
surrog
indic
overal
asthma
sever
number
health
care
provid
visit
hospit
asthma
attack
past
month
past
intens
care
unit
admiss
asthma
found
indic
asthma
one
instanc
detect
picornaviru
could
character
four
children
coinfect
viru
enterovirusposit
patient
coinfect
rhinovirus
rsvposit
child
posit
hmpv
well
sever
significantli
associ
preval
viral
infect
case
patient
control
subject
tabl
iv
also
signific
differ
hospit
nonhospit
case
patient
preval
respiratori
virus
vs
p
symptomat
respiratori
tract
viral
infect
vs
p
case
patient
potenti
effect
use
system
steroid
within
past
week
race
interv
onset
symptom
asthma
exacerb
onset
viral
infect
studi
enrol
rate
pcr
posit
respiratori
virus
analyz
signific
differ
paramet
note
tabl
v
differ
montelukast
use
among
case
patient
control
subject
pauciti
data
regard
potenti
effect
viral
infect
also
analyz
viru
posit
montelukast
use
children
asthma
exacerb
specimen
posit
respiratori
virus
among
receiv
montelukast
versu
among
control
group
posit
rate
respect
differ
montelukast
use
signific
either
group
potenti
relev
factor
eg
atop
statu
use
inhal
corticosteroid
parent
educ
level
famili
incom
exposur
potenti
allergen
home
famili
histori
asthma
also
affect
associ
respiratori
virus
asthma
exacerb
data
shown
rhinoviru
infect
occur
throughout
year
among
case
patient
control
subject
group
highest
overal
activ
observ
april
june
account
fig
ninetyon
particip
case
patient
control
subject
abl
perform
spirometri
accord
american
thorac
societi
standard
fev
distribut
toward
significantli
lower
valu
among
children
acut
versu
control
asthma
p
fisher
exact
test
mean
fev
children
acut
asthma
predict
valu
versu
predict
valu
children
wellcontrol
asthma
p
unpair
student
test
twelv
children
acut
exacerb
asthma
moderatetosever
airway
obstruct
fev
predict
valu
versu
child
wellcontrol
asthma
presenc
viru
respiratori
secret
associ
reduct
fev
among
case
patient
p
control
subject
p
studi
high
proport
children
asthma
rhinoviru
detect
respiratori
secret
rhinovirus
respiratori
virus
associ
asthma
exacerb
result
support
find
previou
investig
acut
exacerb
asthma
significantli
associ
rhinoviru
infect
children
adult
howev
associ
rhinoviru
infect
loss
asthma
control
limit
studi
children
clinic
manifest
symptom
viral
respiratori
tract
ill
strong
associ
asthma
exacerb
symptomat
rhinoviru
infect
extent
differ
case
patient
control
subject
suggest
rhinovirus
might
account
approxim
asthma
exacerb
children
overal
rate
rhinoviru
detect
studi
case
patient
control
subject
compar
report
studi
asthmat
patient
number
factor
could
contribut
role
rhinovirus
asthma
exacerb
includ
abil
replic
cell
lower
airway
tract
stimul
inflammatori
respons
contribut
asthma
exacerb
also
possibl
patient
asthma
suscept
rhinoviru
infect
exampl
defici
immun
respons
rhinoviru
infect
impair
type
cytokin
product
defect
ifnb
previous
describ
asthmat
patient
atopi
might
increas
suscept
rhinoviru
infect
impair
clearanc
result
frequent
persist
rhinoviru
substanti
proport
studi
particip
case
patient
control
subject
infect
rhinovirus
meet
studi
definit
symptomat
although
rate
rhinoviru
posit
without
accompani
acut
respiratori
ill
higher
among
case
patient
among
control
subject
differ
reach
statist
signific
recent
longitudin
studi
healthi
children
rhinoviru
infect
asymptomat
studi
rate
rhinoviru
infect
asthmat
children
without
clinic
manifest
acut
viral
ill
substanti
higher
rhinovirusposit
case
patient
rhinovirusposit
control
subject
basi
high
rate
rhinoviru
infect
without
clinic
appar
symptom
acut
respiratori
ill
asthma
unclear
could
indic
high
rate
persist
infect
possibl
associ
defect
abil
clear
infect
rhinoviru
infect
associ
increas
airway
respons
decreas
pulmonari
function
although
latter
observ
consist
among
asthmat
patient
experiment
rhinoviru
infect
studi
detect
rhinoviru
rna
associ
reduct
fev
within
either
case
patient
control
subject
howev
recent
treatment
bronchodil
corticosteroid
receiv
studi
particip
could
mask
effect
rhinoviru
infect
lung
function
treatment
receiv
asthma
attack
enrol
might
explain
rel
low
proport
case
patient
moderatetosever
airway
obstruct
fev
expect
valu
interestingli
although
rhinovirus
report
peak
activ
spring
fall
found
statist
signific
differ
season
year
rate
rhinoviru
posit
children
poorli
control
asthma
rate
rhinoviru
infect
rang
case
patient
control
subject
highest
level
rhinoviru
activ
observ
spring
month
although
studi
suggest
respiratori
virus
might
also
play
signific
role
exacerb
asthma
present
studi
use
panel
similarli
sensit
pcr
assay
respiratori
virus
found
associ
asthma
exacerb
rhinoviru
season
yeartoyear
geograph
variabl
activ
level
respiratori
virus
differ
patient
popul
specimen
collect
test
methodolog
might
contribut
differ
find
studi
rel
low
preval
human
rsv
infect
studi
consist
exclus
children
younger
year
rsv
import
contributor
obstruct
airway
diseas
children
younger
year
age
older
children
addit
limit
enrol
children
establish
diagnosi
asthma
elimin
children
transient
wheez
episod
often
caus
rsv
similarli
limit
studi
popul
children
older
year
might
also
decreas
hmpv
detect
studi
children
appear
infect
hmpv
young
age
appear
influenza
substanti
contributor
asthma
exacerb
atlanta
area
absenc
influenza
viru
detect
studi
explain
shorter
usual
durat
influenza
season
state
georgia
might
reduc
overal
effect
accord
georgia
divis
public
health
surveil
data
peak
influenza
activ
state
limit
period
decemb
http
healthstategausepiflufluupdallasp
might
miss
influenzaposit
children
small
number
particip
enrol
highrisk
period
decemb
enrol
n
detect
recent
discov
human
bocaviru
studi
particip
bocaviru
detect
asthmat
children
report
addit
studi
potenti
associ
new
viru
asthma
warrant
unlik
mani
studi
respiratori
virus
asthma
collect
respiratori
secret
use
combin
nasopharyng
throat
swab
rather
nasal
lavag
specimen
although
possibl
use
swab
instead
lavag
specimen
decreas
detect
rate
respiratori
virus
potenti
loss
sensit
swab
like
compens
use
sensit
pcr
assay
prove
highli
effect
studi
major
strength
studi
use
panel
sensit
pcr
assay
full
rang
respiratori
virus
enrol
patient
full
calendar
year
frequenc
match
case
patient
control
subject
age
season
enrol
reduc
potenti
bias
associ
tempor
agerel
differ
respiratori
tract
viral
infect
although
certain
differ
baselin
characterist
case
patient
control
subject
eg
recent
treatment
raceethn
number
clinic
visit
hospit
asthma
past
month
might
contribut
differ
viral
infect
preval
none
variabl
significantli
associ
rate
viru
posit
thu
confound
find
one
limit
present
studi
modest
sampl
size
correspond
limit
abil
care
look
subgroup
might
clarifi
identifi
new
find
studi
larger
number
patient
conduct
multipl
year
need
fulli
understand
role
respiratori
virus
asthma
exacerb
better
defin
associ
rhinovirus
summari
found
strong
associ
symptomat
rhinoviru
infect
asthma
exacerb
result
underscor
need
addit
research
better
character
associ
suggest
futur
studi
investig
role
antirhinoviru
treatment
prevent
strategi
decreas
diseas
burden
associ
asthma
